Gregory Cowan, MD
Allergy & Immunology · Peoria, AZNPI 1164756904
Payments from drug & device makers
Across 296 payments — averaging $136.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$35K
- Takeda Pharmaceuticals U.S.A., Inc.$953
- AstraZeneca$686
- Sanofi$586
- GSK$414
- Genentech USA, Inc.$411
- plus $2K from 26 others
What the payments were for
- Consulting fees$1022%
- Food & beverage$4,95496%
- Education$1242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $35,379 |
| Takeda Pharmaceuticals U.S.A., Inc. | 68 | $953 |
| AstraZeneca | 27 | $686 |
| Sanofi | 30 | $586 |
| GSK | 30 | $414 |
| Genentech USA, Inc. | 15 | $411 |
| Novartis | 15 | $267 |
| Shire North American Group Inc | 13 | $188 |
| Regeneron Healthcare Solutions, Inc. | 9 | $183 |
| CSL Behring | 9 | $165 |
| ADMA Biomanufacturing LLC | 12 | $141 |
| Optinose US, Inc. | 8 | $128 |
| Bio Products Laboratory USA, Inc. | 11 | $118 |
| Octapharma USA, Inc. | 2 | $102 |
| Grifols USA, LLC | 4 | $91 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Kaleo, Inc. | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $47 |
| Hikma Pharmaceuticals USA | 2 | $41 |
| Pharming Healthcare, Inc. | 1 | $26 |
| Blueprint Medicines Corporation | 2 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Biocryst US Sales Co., LLC | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Alk-abello, Inc | 1 | $18 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| Merck | 1 | $14 |
| Circassia Inc. | 1 | $14 |
| Jubilant Hollisterstier LLC | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,330 in reported general payments places this provider in the 80th percentile of 90 allergy & immunology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $118,773 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 12 | $80,092 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $27,236 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $18,087 |
| Advair DiskusFluticasone Propion/Salmeterol | 21 | $5,335 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $4,222 |
| Epinephrine | 21 | $2,665 |
| Cromolyn Sodium | 34 | $1,977 |
| Ipratropium Bromide | 57 | $1,369 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 12 | $1,154 |
| Levocetirizine Dihydrochloride | 48 | $1,110 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $789 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 11 | $585 |
| Fluticasone Propionate | 29 | $421 |
| Montelukast Sodium | 35 | $345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $165 | $118,77313 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $953 | $80,09212 claims |
| GSKTrelegy Ellipta | $414 | $27,23643 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $686 | $22,30832 claims |
| Hikma Pharmaceuticals USAEpinephrine | $41 | $2,66521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 90 allergy & immunology providers in Arizona.
Other allergy & immunology in Peoria
- Gilbert OrtegaPeoria$30K
- Ronald MittelPeoria$23K
- Mark RosePeoria$21K
- Ryan CasperPeoria$20K
- Ronald JorgensenPeoria$19K
- Kevin BoeselPeoria$15K
- Eiza ChingPeoria$12K
- Christine PrattPeoria$7K
- Levente ErdosPeoria$2K
- Connie HsuLitchfield Park$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.